|
etibo 250 mg tablet

Lapatinib 250 mg tablet

$60.00 - $165.00
Lapatinib 250 mg tablet is an oral targeted therapy used to treat advanced HER2-positive breast cancer. This medication blocks growth signals on cancer cell surfaces and is typically taken once daily. It is often combined with other chemotherapy agents for improved efficacy.
1

Product Information

Active Ingredient:Lapatinib 250 mg
Manufacturer:Samarth Lifesciences
Country:India

Description

What Is Lapatinib 250 mg Tablet?

Lapatinib 250 mg tablet is an oral cancer medication. Lapatinib is the active ingredient, and each tablet contains 250 mg of it. It is manufactured by Samarth Lifescience. Most patients take several tablets per day to reach the full daily dose their oncologist has set.

What Condition Does It Treat?

Lapatinib is used for advanced or metastatic HER2-positive breast cancer. It is given to patients whose disease has progressed after earlier treatment. Doctors often combine it with capecitabine. It can also cover hormone receptor-positive subtypes alongside HER2-positive disease.

How It Works

Lapatinib blocks two proteins on cancer cell surfaces — HER1 and HER2. Cancer cells use these proteins to receive signals telling them to grow and divide. Block both signals and tumor growth slows down. Lapatinib targets the kinase activity inside these receptors specifically. That dual-target action is why it stays relevant in HER2-positive disease.

How to Take It

Your oncologist sets the exact dose. Take all tablets at the same time each day. They should be taken at least one hour before eating or one hour after not with food. Food increases absorption and can push drug levels beyond the intended range. Do not split or crush the tablets.

Side Effects

Side effects vary in severity. Most patients experience some of the minor effects listed below. Serious effects need immediate attention.

Common side effects:

  • Diarrhea 
  • Nausea and vomiting
  • Skin rash, dryness, or redness on palms and soles
  • Fatigue
  • Mouth sores
  • Loss of appetites

Do not take this drug if you already have liver disease. Tell your doctor about any heart conditions before starting. If you are pregnant, planning to become pregnant, or breastfeeding your baby, this medication is not appropriate.

Who Should Not Take It

Do not use this medication if you have a known allergy to lapatinib or any ingredient in the tablet. Patients with reduced liver function may need dose adjustments or may not be suitable at all. Tell your doctor about all other medications you are taking. Some drugs affect liver enzymes and change how much lapatinib stays active in the body. QT prolongation is a known concern with this drug class. Any existing heart rhythm condition should be disclosed before starting.

Alternatives and Related Products

If this product is not suitable, the following may be relevant depending on your treatment plan:

  • Other HER2-targeted therapies in the kinase blocking category
  • Capecitabine, commonly advised with lapatinib for better treating cancer cells
  • Trastuzumab-based regimens for HER2-positive breast cancer
  • Neratinib, another drug in the same category used in similar settings

Samarth Lifescience produces this tablet for the generic market.

Storage

Store tablets at room temperature, away from moisture and direct sunlight. Keep them in their original packaging until use. Do not store in a bathroom or near a kitchen sink. Humidity can degrade the tablets over time.

Lapatinib tablet price at Fertimeds is listed on the product page. Check the current rate before ordering as pack quantities can affect pricing.

Medical Disclaimer

This product is intended for use by adults only. Always read the label and follow the directions for use. If symptoms persist, worsen, or if you have any concerns, consult your healthcare professional. Do not use this product if you are pregnant, breastfeeding, or have a known medical condition without prior medical advice. Keep out of reach of children. This product is not a substitute for professional medical advice, diagnosis, or treatment. Results may vary between individuals.